CGC - Canopy Growth Corporation Последние новости | Finranks

16.06.2026

Canopy Growth Bought Time, Not A Higher Rating

Canopy Growth Corporation operates across recreational, medical, and cannabinoid-based cannabis markets. I previously rated CGC a Hold, noting that potential cannabis rescheduling benefits seemed priced in. Despite optimism, CGC's subsequent performance validated a more cautious or even bearish stance.

16.06.2026

CGC Q4 Earnings Call Focuses on EBITDA Path

Canopy Growth says its fiscal 2026 reset, MTL integration and medical cannabis growth can drive margin gains and positive adjusted EBITDA in fiscal 2027.

16.06.2026

Where Will Canopy Growth Be in 5 Years?

Canopy Growth has significantly reduced debt. The Canadian company reported 10% revenue growth in fiscal 2026.

15.06.2026

Canopy Growth Corporation (WEED:CA) Q4 2026 Earnings Call Transcript

15.06.2026

Canopy Growth revenue climbs 14% in Q4

Canopy Growth Corporation (TSX:WEED, NYSE:CGC) reported a narrower quarterly loss and double-digit full-year revenue growth on Monday, as the Canadian cannabis company cited the acquisition of MTL Cannabis and a strategic recapitalization as key drivers of its turnaround effort. The company posted an adjusted loss per share of $0.29 for its fiscal fourth quarter, missing analyst estimates, though the result represented a 71% improvement from the $1.01 loss in the same period a year earlier.

15.06.2026

Canopy Growth Q4 Earnings Call Highlights

Canopy Growth NASDAQ: CGC reported higher fiscal fourth-quarter revenue and said it entered fiscal 2027 with a stronger balance sheet following a year of restructuring, cost cuts and the acquisition of MTL Cannabis.

15.06.2026

Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical and 68% in International Markets Cannabis

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announced its financial results for the three months ended March 31, 2026 ("Q4 FY2026") and the fiscal year ended March 31, 2026 ("FY2026"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. “In fiscal 2026, we reset the business, laid a disciplined foundation, and made deliberate investments, including ac.

Видео

18.01.2026

Neutral

How to play cannabis stocks in 2026

19.12.2025

Positive

Trump signs executive order to reschedule cannabis. Here's what's next

Повышения / Понижения рейтинга

Тикер	Фирма	Изменение рейтинга	Целевая цена	Дата
CGC	The Benchmark Company	Hold	undefined >> undefined	November 10th 2025

Пресс-релизы

15.06.2026

Canopy Growth Reports Fourth Quarter and Fiscal Year 2026 Financial Results; Delivers Q4 FY2026 Net Revenue Growth of 27% in Canada Medical and 68% in International Markets Cannabis

Canopy Growth Corporation (CGC)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Canopy Growth Corporation (CGC)

Canopy Growth Bought Time, Not A Higher Rating